117 results
8-K/A
EX-10.1
CHRS
Coherus Biosciences Inc
21 May 24
Financial Statements and Exhibits
5:14pm
:
-7-
(1)in the case that such Lender is a Foreign Lender claiming the benefits of an income tax treaty to which the United States is a party (x … or obligations hereunder or thereunder, or grant a participation in all or any part of, or any interest in, such Lender’s obligations, rights or benefits under
8-K/A
EX-10.2
CHRS
Coherus Biosciences Inc
21 May 24
Financial Statements and Exhibits
5:14pm
and such successors and assigns, any legal or equitable rights hereunder, except that the Indemnified Parties shall be third party beneficiaries of the benefits
8-K
EX-2.1
eyt6d
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
8-K/A
EX-99.1
kmbaltnfs53de0g wh
6 Nov 23
Report of Independent Registered Public Accounting Firm
6:07am
424B5
7ucr 7lq0tor
12 Sep 23
Prospectus supplement for primary offering
6:04am
8-K
EX-99.1
axjl1h0luv qe
8 Sep 23
Coherus Completes Surface Oncology Acquisition
9:12am
424B3
nglq9af iqp
26 Jul 23
Prospectus supplement
4:59pm
S-4/A
m0vx4hd
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
S-4
64qhce
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
425
5o48 23ap
16 Jun 23
Business combination disclosure
5:17pm
425
a4rihbg76
16 Jun 23
Business combination disclosure
5:16pm
425
yusuexf4iwdcer7juo7
16 Jun 23
Business combination disclosure
5:14pm